South Korean Pharmaceuticals & Biotech Big Green Snowflakes

Hyundai ADM Bio

Market Cap: ₩65.0b

A contract research organization, provides clinical services in Asia.

KUKJEON PHARMACEUTICAL

Market Cap: ₩157.6b

Operates as a chemical total solutions provider in South Korea.

Samil PharmaceuticalLtd

Market Cap: ₩269.4b

Engages in the manufacture and sale of indispensable medicines in South Korea.

BioInfra

Market Cap: ₩31.2b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

SAMSUNG PHARM

Market Cap: ₩139.2b

Manufactures and sells pharmaceutical products in South Korea.

PharmAbcine

Market Cap: ₩88.0b

PharmAbcine Inc., a clinical-stage biotech company, develops human therapeutic monoclonal antibody (mAb) for the treatment of neovascular disorders, tumors, and other medically unmet diseases.

CG Invites

Market Cap: ₩155.7b

A biopharma company, engages in the discovery and development of structural chemoproteiomics-based drugs in Korea.

Cellid

Market Cap: ₩76.0b

Develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies.

OLIPASS

Market Cap: ₩9.6b

A biotech company, focuses on developing therapeutic products in South Korea.

Hana Pharm

Market Cap: ₩203.9b

Develops and provides various pharmaceutical products in South Korea and internationally.

Quratis

Market Cap: ₩125.6b

Engages in developing vaccines in South Korea.

Plumbline Life Sciences

Market Cap: ₩21.1b

Engages in the development and sale of DNA medicines for animals.

Polaris AI Pharma

Market Cap: ₩99.9b

Engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally.

Kainos Medicine

Market Cap: ₩39.5b

Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.

BioInfra Life Science

Market Cap: ₩6.1b

A healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.

Eone Diagnomics Genome Center

Market Cap: ₩57.4b

Provides genetic information analysis services in South Korea.

Samjin Pharmaceuticals

Market Cap: ₩217.8b

Manufactures and sells medicine.

GI Innovation

Market Cap: ₩921.7b

A bio-venture company, engages in the research and development of protein new drugs.

Power Fulx

Market Cap: ₩4.5b

Manufactures and sells muscle pain relief, body slimming, and sun protection creams in South Korea.

Epibiotech

Market Cap: ₩25.2b

A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.

IMB Dx

Market Cap: ₩123.4b

Provides liquid biopsy platform in South Korea.

Future Medicine

Market Cap: ₩14.8b

Operates as a drug development company worldwide.

Apures

Market Cap: ₩6.5b

Engages in the development and commercialization of solutions for the bio and medical industries in South Korea.

Ensol Biosciences

Market Cap: ₩287.1b

A biopharmaceutical company, develops bio drugs for the treatment of degenerative disc, osteoarthritis, cancer, type 1 diabetes, and Alzheimer's dementia diseases.

ROKIT HEALTHCARE

Market Cap: ₩105.8b

A biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea.

Seoul Pharma

Market Cap: ₩39.2b

Manufactures and sells pharmaceutical products in South Korea and internationally.

Hwail PharmaceuticalLtd

Market Cap: ₩88.8b

Develops pharmaceutical raw materials in South Korea.

Progen

Market Cap: ₩94.0b

A biotechnology company, engages in platform-based drug discovery and development activities.

Curachem

Market Cap: ₩20.0b

Provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development.

Curable

Market Cap: ₩4.3b

Provides single nucleotide polymorphism (SNP) research and analysis services in South Korea.

HK inno.N

Market Cap: ₩1.2t

Engages in the pharmaceutical business in South Korea.

SunBioInc

Market Cap: ₩96.3b

A biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide.

Inventage Lab

Market Cap: ₩542.4b

Inventage Lab Inc., a platform technology company, develops medicines using microfluidics based drug delivery systems.

SLS BIO

Market Cap: ₩28.9b

Develops diagnostic technologies in South Korea.

Choong Ang Vaccine Laboratory

Market Cap: ₩90.9b

Operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea.

Aptamer Sciences

Market Cap: ₩32.6b

A bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.